Apexigen (APGN) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $0.39
▼
$0.39
50-Day Range: $0.36
▼
$0.44
52-Week Range: $0.33
▼
$8.28

Volume: N/A
Average Volume: 967,731 shs
Market Capitalization: $9.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.50

Stock Analysis Analyst Forecasts Earnings Headlines Ownership Short Interest Social Media

Source

Source	Headline
	Pyxis Oncology: Catalysts Ahead, Cash In Hand And An Acquisition Completed seekingalpha.com - September 7 at 8:34 AM
	marketbeat.com - August 23 at 6:04 AM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, CPRI, APGN markets.businessinsider.com - August 11 at 3:47 PM
	Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting finance.yahoo.com - June 3 at 8:10 AM
	EF Hutton Reiterates Apexigen (APGN) Hold Recommendation msn.com - May 27 at 10:06 AM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNL, RTL, APGN markets.businessinsider.com - May 24 at 2:58 PM
	EF Hutton Maintains Apexigen (APGN) Buy Recommendation msn.com - May 17 at 3:48 AM
	APG SGA S.A. wsj.com - May 16 at 3:58 AM
	Are Medical Stocks Lagging Apexigen, Inc. (APGN) This Year? finance.yahoo.com - March 3 at 3:18 PM
	Are Medical Stocks Lagging Apexigen, Inc. (APGN) This Year? finance.yahoo.com - March 3 at 3:18 PM
	Apexigen Announces Review of Strategic Alternatives and Restructuring finance.yahoo.com - February 27 at 10:48 AM
	Apexigen Announces Approximately $2.8 Million Private Placement Financing finance.yahoo.com - January 24 at 8:56 AM
	Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket msn.com - January 23 at 10:11 AM
	Apexigen Touts New Positive Sotigalimab Data Showing Expanded Anti-Tumor Responses finance.yahoo.com - January 19 at 5:41 PM
	Thinking about buying stock in Zymeworks, CureVac, Apexigen, Gamida Cell, or Xos? benzinga.com - January 19 at 12:36 PM
	Apexigen Announces New Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, at ASCO Gastrointestinal Cancers Symposium 2023 finance.yahoo.com - January 19 at 12:36 PM
	Apexigen Shares Halted On Circuit Breaker To The Upside, Stock Now Up 140.5% benzinga.com - January 11 at 11:38 PM
	marketbeat.com - January 9 at 3:24 PM
	marketbeat.com - January 9 at 9:50 AM
	marketbeat.com - January 9 at 9:44 AM
	Apexigen Reports Third Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - November 15 at 11:20 AM
	Apexigen Announces New Data from a Phase 1/2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Pembrolizumab in Patients with First-Line Metastatic Melanoma at the SITC 2022 Annual Meeting finance.yahoo.com - November 11 at 9:55 AM
	How biotech companies are building drug pipelines with PIPEs bizjournals.com - November 4 at 5:09 AM
	Wall Street Set to Open Lower as Higher-Than-Expected UK Inflation Rattles Investors msn.com - October 19 at 10:00 AM
	Apexigen, Inc. (APGN) ca.finance.yahoo.com - October 6 at 2:06 PM
	Apexigen's Shares Fall After Data From Gastric Cancer Candidate finance.yahoo.com - September 12 at 4:32 PM
	Apexigen Presents New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022 finance.yahoo.com - September 10 at 9:26 AM
	Apexigen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com - September 7 at 10:48 AM
	Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022 finance.yahoo.com - September 5 at 8:59 AM
	Apexigen, Inc. Rings the Closing Bell nasdaq.com - September 2 at 6:11 PM
	marketbeat.com - August 26 at 10:15 AM
	marketbeat.com - August 19 at 2:11 PM
	Apexigen to Participate in the 2022 Wedbush PacGrow Healthcare Conference finance.yahoo.com - August 16 at 4:41 PM
	Is Apexigen (NASDAQ:APGN) In A Good Position To Deliver On Growth Plans? finance.yahoo.com - August 16 at 4:41 PM
	marketbeat.com - August 12 at 11:19 AM
	marketbeat.com - August 12 at 11:13 AM
	marketbeat.com - August 2 at 2:18 PM
	marketbeat.com - August 1 at 10:59 AM
	marketbeat.com - August 1 at 10:45 AM
	marketbeat.com - August 1 at 10:32 AM
	marketbeat.com - August 1 at 10:27 AM
	marketbeat.com - August 1 at 10:02 AM
	marketbeat.com - August 1 at 9:37 AM

Get Apexigen News Delivered to You Automatically

APGN Media Mentions By Week

APGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APGN
News Sentiment
▼
0.00

0.84
▲
Average
Medical
News Sentiment

APGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APGN Articles
This Week
▼
0

0
▲
APGN Articles
Average Week

Get Apexigen News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:APGN) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Apexigen (APGN) News Today

APGN Media Mentions By Week

APGN Media Sentiment

APGN News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info